• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Breast Cancer

Oncology Solutions

Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year. According to the WHO, it is estimated that 627,000 women died from breast cancer in 2018 which represents 15 percent of all cancer deaths among women.1 GE Healthcare has the largest global installed base for breast imaging covering the entire breast cancer continuum. The breast cancer portfolio includes 2D and 3D Mammography, Ultrasound, Automated Breast Ultrasound, MRI, CT and PET/CT. Together the Mammography and ABUS modalities are endorsed by more than 100 clinical publications worldwide.

The Patient Journey

Early detection of prostate cancer can help to detect the cancer at an earlier stage, helping patients get access to the treatment they require. One of the most common types of pro
Senographe Pristina Mammography System
Learn More
Pristina Dueta
Learn More
Invenia ABUS 2.0
Learn More
SensorySuite
Seno Iris GE Mammography Solution
Learn More
SIGNA™ Artist - 70cm
Learn More
READY View
Learn More
Colorectal Cancer - Diagnosis, a wide range of diagnostic tools available to study patients with CRC, including optical colonoscopy, double contrast barium enema (DCBE), computed t
SenoBright HD
Learn More
Advanced imaging is important for staging and treating a broad range of clinical cases. Multidisciplinary teams require precise visualization and density information to determine s
LOGIQ™ E10 Ultrasound Series
Learn More
SIGNA™ Architect AIR™ Edition
Learn More
Computed Tomography
Learn More
PET/CT
Learn More
Invenia ABUS 2.0
Learn More
Dependant on what stage the prostate cancer is when diagnosed, different treatment plans will be put in place. GE Healthcare is able to combine advanced imaging and visualization a
Discovery RT
Learn More
MR Radiation Oncology Suite
Invenia ABUS 2.0
Learn More
LOGIQ™ E10 Ultrasound Series
Learn More
Discovery RT
Learn More
Active surveillance instead of immediate treatment may be appropriate for many men diagnosed with prostate cancer especially in the early stages. GE Healthcare's technology can hel
LOGIQ™ E10 Ultrasound Series
Learn More
SIGNA™ PET/MR with QuantWorks – 60cm
Learn More
READY View
Learn More
Invenia ABUS 2.0
Learn More
Certain hematological malignancies have high recurrence rates. GE Healthcare has a range of diagnostic tools to monitor disease recurrence, disease progression and response to ther
Seno Iris GE Mammography Solution
Learn More
Invenia ABUS 2.0
Learn More
LOGIQ™ E10 Ultrasound Series
Learn More
SIGNA™ PET/MR with QuantWorks – 60cm
JB04823XX